These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 8886562)

  • 1. Serum lipoproteins in African Americans and whites with non-insulin-dependent diabetes in the US population.
    Cowie CC; Howard BV; Harris MI
    Circulation; 1994 Sep; 90(3):1185-93. PubMed ID: 8087927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians.
    Rubin J; Paultre F; Tuck CH; Holleran S; Reed RG; Pearson TA; Thomas CM; Ramakrishnan R; Berglund L
    J Lipid Res; 2002 Feb; 43(2):234-44. PubMed ID: 11861665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study.
    Marcovina SM; Albers JJ; Jacobs DR; Perkins LL; Lewis CE; Howard BV; Savage P
    Arterioscler Thromb; 1993 Jul; 13(7):1037-45. PubMed ID: 8318505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum distribution of lipoprotein(a) in African Americans and Nigerians: potential evidence for a genotype-environmental effect.
    Rotimi CN; Cooper RS; Marcovina SM; McGee D; Owoaje E; Ladipo M
    Genet Epidemiol; 1997; 14(2):157-68. PubMed ID: 9129961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans.
    Mooser V; Scheer D; Marcovina SM; Wang J; Guerra R; Cohen J; Hobbs HH
    Am J Hum Genet; 1997 Aug; 61(2):402-17. PubMed ID: 9311746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DQ associations distinguish insulin-resistant and insulin-sensitive variants of NIDDM in black Americans.
    Banerji MA; Norin AJ; Chaiken RL; Lebovitz HE
    Diabetes Care; 1993 Feb; 16(2):429-33. PubMed ID: 8432213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between physical activity, cardiorespiratory fitness, and lipoprotein(a) concentrations in a tri-ethnic sample of women: The Cross-Cultural Activity Participation Study.
    Drowatzky KL; Durstine JL; Irwin ML; Moore CG; Davis PG; Hand GA; Gonzalez MF; Ainsworth BE
    Vasc Med; 2001; 6(1):15-21. PubMed ID: 11358155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of lipoprotein(a) levels in a biracial cohort of young girls: the NHLBI Growth and Health Study.
    Kimm SY; Pasagian-Macaulay A; Aston CE; McAllister AE; Glynn NW; Kamboh MI; Ferrell RE
    J Pediatr; 1999 Aug; 135(2 Pt 1):169-76. PubMed ID: 10431110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between parental history of type 2 diabetes and glycemic control in urban African Americans.
    Gong L; Kao WH; Brancati FL; Batts-Turner M; Gary TL
    Diabetes Care; 2008 Sep; 31(9):1773-6. PubMed ID: 18535188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heritability of apolipoprotein (a) traits in two-generational African-American and Caucasian families.
    Enkhmaa B; Anuurad E; Zhang W; Kim K; Berglund L
    J Lipid Res; 2019 Sep; 60(9):1603-1609. PubMed ID: 31324652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between lipoprotein (a) and micro/macro complications in type 2 diabetes mellitus: a forgotten target.
    Toro R; Segura E; Nuñez-Cortes JM; Pedro-Botet JC; Quezada-Feijoo M; Mangas A
    J Geriatr Cardiol; 2015 Mar; 12(2):93-9. PubMed ID: 25870610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size.
    Rainwater DL; MacCluer JW; Stern MP; VandeBerg JL; Haffner SM
    Diabetes; 1994 Jul; 43(7):942-6. PubMed ID: 8013760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
    Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
    Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different change in lipoprotein(a) levels from lipid levels of other lipoproteins with improved glycemic control in patients with NIDDM.
    Kikuchi T; Onuma T; Shimura M; Tsutsui M; Boku A; Matsui J; Takebe K
    Diabetes Care; 1994 Sep; 17(9):1059-61. PubMed ID: 7988307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) in android obesity and NIDDM.
    Wassef N; Sidhom G; Zakareya el-K ; Mohamed el-K
    Diabetes Care; 1997 Nov; 20(11):1693-6. PubMed ID: 9353610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein (a) levels in African-Americans with NIDDM.
    Scheer WD; Boudreau DA; Cook CB
    Diabetes Care; 1996 Oct; 19(10):1129-34. PubMed ID: 8886562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients.
    Hirata K; Saku K; Jimi S; Kikuchi S; Hamaguchi H; Arakawa K
    Diabetologia; 1995 Dec; 38(12):1434-42. PubMed ID: 8786017
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.